A long-standing dispute over the approach to country of origin determinations under the Trade Agreements Act (“TAA”) may soon be resolved, as the Federal Circuit recently heard oral argument in one of two cases presently examining key aspects of this statute. Among other questions presented, the court may decide the standard for determining whether a product may be considered a U.S.-made end product — a question that could have far reaching implications for product manufacturers across all industries.
More Posts
Rights in Government-Funded IP: Changes May be on the Horizon
More Novation Complexity In Gov’t Contracts M&A?
4 Considerations For Gov’t Contractor Carveout Deals
Fraudulent SAM Accounts Lead to More Complicated SAM Registration Requirements
The Long-Standing TAA “Substantial Transformation” Standard for Drug Products is Challenged at the Court of International Trade
California Law Aims to Scrutinize Drug Pricing
Protecting Intellectual Property as Government R&D Funding Rises
Senate Committee Directs DoD to Reduce Drug Prices
Department of State Releases 2017 TIP Report
Connect: http://www.cov.com/ahastings/
Subscribe: Subscribe via RSS